Argen X SE - ADR
NASDAQ:ARGX 4:00:00 PM EDT
| Market Cap (Intraday) | 21.16B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 103.79 |
| 10-Day MA | $374.73 |
| 50-Day MA | $381.27 |
| 200-Day MA | $436.63 |
Argen X SE - ADR Stock, NASDAQ:ARGX
Laarderhoogtweg 25, Amsterdam, Noord-Holland 1101 EB
Belgium
Phone: +31.76.303.04.88
Number of Employees: 1148
Description
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.